ABBV has been in the news 346% more than usual
Sep 17, 2025, 6:31 PM
2.71%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: AbbVie's short interest has decreased by 9.38%, with 15.40 million shares sold short, which represents 0.87% of the company's available shares. This decline in short interest may indicate increased investor confidence in AbbVie's performance.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.